Sentinel lymph node mapping and biopsy for ductal carcinoma in situ and other controversial indications

American Surgeon

Volumn 70, Issue 5, 2004, Pages 403-406

  Fuhrman, George M ^a  

^a OCHSNER CLINIC FOUNDATION   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT;

ADJUVANT CHEMOTHERAPY; ADJUVANT THERAPY; BIOPSY; BREAST TUMOR; EVIDENCE BASED MEDICINE; FEMALE; HUMAN; LABORATORY DIAGNOSIS; MASTECTOMY; METHODOLOGY; PAGET NIPPLE DISEASE; PATHOLOGY; PATIENT SELECTION; PRACTICE GUIDELINE; PREOPERATIVE CARE; REPRODUCIBILITY; REVIEW; SENSITIVITY AND SPECIFICITY; SENTINEL LYMPH NODE BIOPSY; STANDARD;

ANTINEOPLASTIC AGENTS; BIOPSY; BREAST NEOPLASMS; CARCINOMA, INTRADUCTAL, NONINFILTRATING; CHEMOTHERAPY, ADJUVANT; EVIDENCE-BASED MEDICINE; FALSE NEGATIVE REACTIONS; FEMALE; HUMANS; MASTECTOMY; NEOADJUVANT THERAPY; PATIENT SELECTION; PRACTICE GUIDELINES; PREOPERATIVE CARE; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; SENTINEL LYMPH NODE BIOPSY;

EID: 2542513130     PISSN: 00031348     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (28)

1. Giuliano AE. Mapping a pathway for axillary staging: A personal perspective on the current status of sentinel node dissection for breast cancer. Arch Surg 1999;134:195-199
2. Lagios MD, Westdahl PR, Margolin FR, Rose MR. Duct carcinoma in situ. Relationship of extent of noninvasive disease to the frequency of occult invasion, multicentricity, lymph node metastases, and short-term treatment failures. Cancer 1982;50:1309-1314
3. Fisher ER, Sass R, Fisher B, et al. Pathologic findings from the National Surgical Adjuvant Breast Project (protocol 6). I. Intraductal carcinoma (DCIS). Cancer 1986;57:197-208.
4. Lagios MD, Margolin FR, Westdahl PR, Rose MR. Mammographically detected duct carcinoma in situ. Frequency of local recurrence following tylectomy and prognostic effect of nuclear grade on local recurrence. Cancer 1989;63:618-624
5. Silverstein MJ, Gierson ED, Waisman JR, et al. Axillary lymph node dissection for T1a breast carcinoma. Is it indicated? Cancer 1994;73:664-667
6. Feldman SM, Krag DN, McNally RK, et al. Limitation in gamma probe localization of the sentinel node in breast cancer patients with large excisional biopsy. J Am Coll Surg 1999;188:248-254
7. Fuhrman GM, Cederbom GJ, Bolton JS, et al. Image-guided core-needle breast biopsy is an accurate technique to evaluate patients with nonpalpable imaging abnormalities. Ann Surg 1998;227:932-939
8. Jackman RJ, Burbank F, Parker SH, et al. Stereotactic breast biopsy of nonpalpable lesions: Determinants of ductal carcinoma in situ underestimation rates. Radiology 2001;218:497-502. (Pubitemid 32121065)
9. Pendas S, Dauway E, Giuliano R, et al. Sentinel node biopsy in ductal carcinoma in situ patients. Ann Surg Oncol 2000;7:15-20. (Pubitemid 30078488)
10. Cox CE, Nguyen K, Gray RJ, et al. Importance of lymphatic mapping in ductal carcinoma in situ (DCIS): Why map DCIS? Am Surg 2001;67:513-521 (Pubitemid 33738842)
11. Klauber-DeMore N, Tan LK, Liberman L, et al. Sentinel lymph node biopsy: Is it indicated in patients with high-risk ductal carcinoma-in-situ and ductal carcinoma-in-situ with microinvasion? Ann Surg Oncol 2000;7:636-642 (Pubitemid 30764728)
12. Kelly TA, Kim JA, Patrick R, et al. Axillary lymph node metastases in patients with a final diagnosis of ductal carcinoma in situ. Am J Surg 2003;186:368-370 (Pubitemid 38368612)
13. Intra M, Veronesi P, Mazzarol C, et al. Axillary sentinel lymph node biopsy in patients with pure ductal carcinoma in situ of the breast. Arch Surg 2003;138:309-313 (Pubitemid 36292666)
14. Farkas EA, Stolier AJ, Teng SC, et al. An argument against routine sentinel node mapping for DCIS. Am Surg 2004;70:13-18
15. Schrenk P, Wayand W. Sentinel-node biopsy in axillary lymph-node staging for patients with multicentric breast cancer (letter). Lancet 2001;357:122. (Pubitemid 32094920)
16. Tousimis E, Van Zee KJ, Fey JV, et al. The accuracy of sentinel lymph node biopsy in multicentric and multifocal invasive breast cancers. J Am Coll Surg 2003;197:529-535 (Pubitemid 38223835)
17. Layeeque R, Henry-Tillman R, Korourian S, et al. Subareolar sentinel node biopsy for multiple breast cancers. Am J Surg 2003;186:730-736 (Pubitemid 37522114)
18. D'Eredia' G, Ferrarese F, Cecere V, et al. Subareolar injection may be more accurate that other techniques for sentinel lymph node biopsy in breast cancer. Ann Surg Oncol 2003;10:942-947 (Pubitemid 40486861)
19. Kern KA. Concordance and validation study of sentinel lymph node biopsy for breast cancer using subareolar injection of blue dye and technetium 99m sulfur colloid. J Am Coll Surg 2002;195:467-475
20. Tuttle TM, Colbert M, Christensen R, et al. Subareolar injection of 99mTc facilitates sentinel lymph node identification. Ann Surg Oncol 2002;9:77-81. (Pubitemid 34262901)
21. Balch GC, Mithani SK, Richards KR, et al. Lymphatic mapping and sentinel lymphadenectomy after preoperative therapy for stage II and III breast cancer. Ann Surg Oncol 2003;10:616-621
22. Brady EW. Sentinel lymph node mapping following neoadjuvant chemotherapy for breast cancer. Breast J 2002;8:97-100. (Pubitemid 34233588)
23. Schwartz GF, Meltzer AJ. Accuracy of axillary sentinel lymph node biopsy following neoadjuvant (induction) chemotherapy for carcinoma of the breast. Breast J 2003;9:374-379 (Pubitemid 37158910)
24. Julian TB, Dusi D, Wolmark N. Sentinel node biopsy after neoadjuvant chemotherapy for breast cancer. Am J Surg 2002;184:315-317 (Pubitemid 35287349)
25. Reitsamer R, Peintinger F, Rettenbacher L, et al. Sentinel lymph node biopsy in breast cancer patients after neoadjuvant chemotherapy. J Surg Oncol 2003;84:63-67 (Pubitemid 37247910)
26. Breslin TM, Cohen L, Sahin A, et al. Sentinel lymph node biopsy is accurate after neoadjuvant chemotherapy for breast cancer. J Clin Oncol 2000;18:3480-3486 (Pubitemid 30783326)
27. Sabel MS, Schott AF, Kleer CG, et al. Sentinel node biopsy prior to neoadjuvant chemotherapy. Am J Surg 2003;186:102-105 (Pubitemid 37289077)
28. Halstead WS. The results of operations for the cure of cancer of the breast performed at the Johns Hopkins Hospital from June 1889 to January 1894. Johns Hopkins Hosp Bull 1894-1895;4:297.